Detalles de la búsqueda
1.
BNT162b2 mRNA Vaccination Against Coronavirus Disease 2019 is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5-18 Years-United States, July 2021 - April 2022.
Clin Infect Dis
; 76(3): e90-e100, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35924406
2.
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.
MMWR Morb Mortal Wkly Rep
; 71(2): 52-58, 2022 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35025852
Resultados
1 -
2
de 2
1
Próxima >
>>